Rigel Pharmaceuticals (RIGL)
(Delayed Data from NSDQ)
$21.91 USD
+0.85 (4.04%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $21.88 -0.03 (-0.14%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
Rigel Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
RIGL 21.91 +0.85(4.04%)
Will RIGL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RIGL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RIGL
Collegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards?
Why Rigel (RIGL) Could Beat Earnings Estimates Again
RIGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Rigel (RIGL) Climb 69.55% to Reach the Level Wall Street Analysts Expect?
Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now?
Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now?
Other News for RIGL
Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and ...
RIGL Crosses Above Key Moving Average Level
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | ...
RIGL Makes Bullish Cross Above Critical Moving Average
Nuvation Bio: Judgement Day Grows Closer